According to Fact.MR, the market for preimplantation genetic testing is likely to register an impressive valuation by 2031. Increasing prevalence of genetic disorders is broadening growth prospects. The market is projected to grow at nearly 9% CAGR through 2031.
Key Points Covered in Preimplantation Genetic Testing Industry Survey:
- Market Estimates and Forecasts (2017-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- Assessment by Product Grade / Purity / Formulation Standards
- Assessment of Import Price, Bulk Price, Contractual Price, Producer / Distributor Price
- Certifications and Compliance Requirements
- COVID-19 Impact on the Preimplantation Genetic Testing Sales and How to Navigate
- Recommendation on Key Winning Strategies
Know More Details About the Report
Consumption Analysis of Preimplantation Genetic Testing from 2016-2020 Vs Market Outlook for 2021 to 2031
As per Fact.MR – a market research and competitive intelligence provider- over the last 5 years, the global market for preimplantation genetic testing expanded at 8% CAGR. In 2020, the market was valued at around US$ 550 Mn.
Preimplantation genetic testing is gaining traction for diagnosing minor disabilities and other serious diseases such as cancer. Researchers are also focusing on using innovative techniques for eliminating the possibility of embryo destruction while preimplantation genetic testing.
All these factors create an ideal environment for preimplantation genetic testing across the world, and the market is expected to show an impressive valuation by 2031, expanding at nearly 9% CAGR.
How Has COVID-19 Impacted Demand for Preimplantation Genetic Testing?
Demand for preimplantation genetic testing declined substantially in the initial months of the COVID-19 pandemic. Restrictions on clinic genetics were amongst the most visible effects of the impact.
Countries have effectively shut down their testing units, putting a strain on equipment manufacturers. As a result of the pandemic, telemedicine-based consultations and counseling were adopted globally.
Policymakers, worldwide, have announced massive monetary and fiscal stimuli to mitigate the pandemic’s economic fallout to keep financially starved businesses stay afloat. These measures are anticipated to leverage the global preimplantation genetic testing market.
Furthermore, as the months passed, key healthcare providers leveraged every possible resource to develop efficient and swift diagnostic testing approaches to detect the novel coronavirus amongst patients. This has boded well for preimplantation genetic testing.
Avail customized purchase options for your needs
How is Genetic Screening across Specialized Clinics Fueling Global Demand?
Genetic screening is expected to be the most preferred preimplantation genetic testing approach. The section is projected to gain a nearly 2/3rd share of the market for preimplantation genetic testing in terms of revenue until 2031.
According to the Centers for Disease Control and Prevention (CDC), chronic ailments such as cancer, heart disorders, and diabetes are the leading cause of disability and deaths of people across the United States.
The country’s healthcare system spends nearly US$ 3 Bn annually on direct and indirect costs. In addition to this, the increasing awareness regarding the effectiveness of genetic testing methods amongst healthcare professionals is projected to favor market growth in forthcoming years.
Amongst all end users, specialized clinics are expected to experience strong growth. They are estimated to exceed the US$ 200 Mn revenue threshold during the forecast period. Meanwhile, hospitals are also expected to witness impressive growth in the global market for preimplantation genetic testing through 2031.
In June 2020, The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next-generation sequence technology. The FDA authorized the Illumina COVIDSeq Test for the qualitative detection of SARS-CoV-2 RNA from respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.
Which Region Offers the Largest Opportunity for Preimplantation Genetic Testing Providers?
North America represents the largest opportunity for preimplantation genetic testing service providers. Growing number of chromosome abnormality cases in the region leads to various genetic disorders. A CAGR of 7% has been projected for the market.
According to CDC, each year, about 6,000 babies are born with Down syndrome, which is about 1 in every 700 babies born. Down syndrome among newborn babies in the U.S continues to be the most common chromosomal disorder, broadening scope of preimplantation genetic testing across the North American region.
An Adaptive Approach to Modern-day Research Needs
What is the Demand Outlook for Preimplantation Genetic Testing in the U.K?
The UK is projected to be the most lucrative market for preimplantation genetic testing across Europe. Fact.MR estimates a CAGR of around 8% for the U.K market across the forecast period.
In 2021, the market demand is projected to bolster, owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government.
Moreover, genetic testing in the U.K increasing as the country amid high incidence of genetic disorders. According to Genetic Alliance, it is estimated that at least 1 child out of 25 is affected by a genetic disorder. This means that 30,000 babies are diagnosed each year and more than 500 million children and adults are living with a genetic disorder. Owing to these factors, the market is projected to expand through 2031.
What are the Growth Opportunities for Preimplantation Genetic Testing across India and China?
Emerging economies such as China and India are experiencing numerous advancements in their respective healthcare sectors. Reproductive health is especially accompanied by launch of several supportive governmental legislations. Collectively, both regions are expected to contribute nearly 60% of total revenue.
Presence of regulatory bodies, such as the Indian Ministry of Health & Family Welfare, which approves and monitor the challenges associated with reproductive health in India: is anticipated to bode well for regional growth of the market for preimplantation genetic testing.
Have a report related query? Speak to us directly
How is Demand for Embryo HLA typing for Stem Cell Therapy Gaining Ground?
Preimplantation genetic testing is likely to find maximum application in embryo HLA typing for stem cell therapy.
Accounting for more than 40% revenue, embryo HLA typing for stem cell therapy is projected to generate an incremental opportunity exceeding US$ 70 Mn by 2031.
How is Next-Generation Sequencing Technology Generating Demand?
Next-generation sequencing (NGS) is expected to be the dominant preimplantation genetic testing technology. NGS is estimated to exceed US$ 200 Mn in revenue during the forecast period.
According to the Center for Disease Control and Prevention during the past 5 years, NGS has transitioned from research to clinical use. At least 14 countries have created initiatives to sequence large populations, and it is projected that more than 60 million people worldwide will have their genome sequenced by 2025.
Preimplantation genetic testing market is a highly consolidated market in which a small group of players accounts for near half of the global sales.
In May 2021, United Airlines and Abbott Laboratories announced a collaboration to use Abbott’s BinaxNOW™ COVID-19 Home Test and Abbott’s NAVICA app to help make the international travel experience more seamless.
The CDC guidelines permit travelers to self-administer a rapid antigen test under the real-time supervision of a telehealth service and use the verified negative test result to board an international flight to the U.S. if they test negative.
Historical Data Available for
|US$ Mn for Value & ‘000 Units for Volume|
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered
- Preimplantation Genetic Diagnostics
- Preimplantation Genetic Screening
- Preimplantation Genetic Testing in Hospitals
- Preimplantation Genetic Testing in Diagnostic Labs
- Preimplantation Genetic Testing in Research & Academic Institutions
- Preimplantation Genetic Testing in Specialized Clinics
- Preimplantation Genetic Testing by Other End Users
- Preimplantation Genetic Testing for Embryo HLA Typing for Stem Cell Therapy
- Preimplantation Genetic Testing for IVF Prognosis
- Preimplantation Genetic Testing for Late-Onset Genetic Disorders
- Preimplantation Genetic Testing for Inherited Genetic Diseases
- Preimplantation Genetic Testing for Other Applications
- NGS-based Preimplantation Genetic Testing
- PCR-based Preimplantation Genetic Testing
- FISH-based Preimplantation Genetic Testing
- CGH-based Preimplantation Genetic Testing
- SNP-based Preimplantation Genetic Testing
Preimplantation Genetic Testing Market- Report Scope
A recent study by Fact.MR on the preimplantation genetic testing market offers a 10-year forecast from 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market.
This report explicates vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering preimplantation genetic testing.
The study also provides the dynamics responsible for influencing the future status of the preimplantation genetic testing market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the preimplantation genetic testing market, along with their product portfolios, enhances the reliability of this comprehensive research study.
The study offers a comprehensive analysis of diverse features, including production capacities, demand, product developments, revenue generation, and sales of preimplantation genetic testing across the globe.
A comprehensive estimate of the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of preimplantation genetic testing during the forecast period. Price point comparison by region with the global average price is also considered in the study.
Key Questions Answered in Report
- Which are the most lucrative preimplantation genetic testing markets?
- Which factors will impact the growth of preimplantation genetic testing market?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the preimplantation genetic testing industry?
- What are the winning strategies of stakeholders in the market?
Analysis on Market Size Evaluation
The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).
Estimates at global and regional levels for the preimplantation genetic testing market are available in terms of “US$ Mn” for value and in “‘000 Units” for volume.
A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.
Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global preimplantation genetic testing market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which has helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the preimplantation genetic testing market during the forecast period.
Country-specific valuation on demand for preimplantation genetic testing has been offered for each region, along with market scope estimated rates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries.
For all regional markets, Y-o-Y growth estimates have also been incorporated in the report. Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
In-depth Competition Analysis
The report sheds light on leading providers of preimplantation genetic testing, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering preimplantation genetic testing have been brought with the help of a detailed dashboard view.
Market share analysis and comparison of prominent players provided in the report permit report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which includes essentials such as product portfolios and key strategies, along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the preimplantation genetic testing market domain.
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the preimplantation genetic testing Industry, and reach conclusions on the future growth parameters. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases.
Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
- FAQs -
As of 2020, the preimplantation genetic testing services market reached US$ 550 Mn
From 2016 to 2020, preimplantation genetic testing services expanded at around 8% CAGR
The market for preimplantation genetic testing is poised to expand at above 9% CAGR until 2031
Preimplantation genetic screening is acquiring traction, amid growing need to screen infants for possible prevalence of Down syndrome
North America represents the most opportunistic market, growing at 7% CAGR
The U.K preimplantation genetic testing landscape is poised to grow at around 8% CAGR
India and China will likely account for 60% of overall demand for preimplantation genetic testing until 2031
Testing for embryo HLA typing for stem cell therapy is likely to generate incremental opportunity exceeding US$ 70 Mn by 2031
Next generation sequencing (NGS) is estimated to exceed US$ 200 Mn in revenue during the forecast period.
Agilent Technologies, Abbott Laboratories, Illumina Inc. and Thermo Fisher Scientific are some prominent preimplantation genetic testing service providers
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.